Méningites à Haemophilus influenzae à Bobo-Dioulasso (Burkina Faso)

Tall, F.; Elola, A.; Prazuck, Thiérry; Traoré, Amidou; Nacro, B.; Vincent-Ballereau, F.

doi:10.1016/s0399-077x(05)81433-7

Cited by 6 publications

(10 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Table 1 lists 50 studies of bacterial meningitis in 25 countries and regions . Prospectively collected data were obtained from Burkina Faso [13], Cameroon [15], Ghana [31], Libya [39], Nigeria [46,48], South Africa [56,57], Swaziland [59], and Zambia [61]. More than 30,000 cases were reported overall, but in only 37 studies (total no.…”

Section: Methodsmentioning

confidence: 99%

“…In 2 prospective studies (in Burkina Faso [13] and Swaziland [59]), Hib, rather than S. pneumoniae, proved to be the most likely bacterial species to lead to sequelae in patients recovering from bacterial meningitis; the rates in the Burkina Faso and Swaziland were 14% and 38% for Hib, 5% and 16% for pneumococci, and zero and 20% for meningococci, respectively. In contrast, a recent survey in The Gambia [71] revealed long-term sequelae (determined at examinations performed 11-90 months after illness) in 58% of cases of pneumococcal meningitis, compared with 38% of cases of Hib meningitis.…”

Section: Complications and Sequelaementioning

confidence: 98%

“…It is not surprising that H. influenzae was of greater importance when only the pediatric cases were considered; sometimes it was more common than meningococcus, even in the meningitis belt: in Burkina Faso in 1986-1990 [13] and in northwestern Ethiopia in 1990-1994 [27]. This reflects the epidemic nature of meningococcal disease.…”

Section: Meningitismentioning

confidence: 99%

“…Seven studies evaluated sequelae according to etiology [13,14,25,41,43,59,71]. In 2 prospective studies (in Burkina Faso [13] and Swaziland [59]), Hib, rather than S. pneumoniae, proved to be the most likely bacterial species to lead to sequelae in patients recovering from bacterial meningitis; the rates in the Burkina Faso and Swaziland were 14% and 38% for Hib, 5% and 16% for pneumococci, and zero and 20% for meningococci, respectively.…”

Section: Complications and Sequelaementioning

confidence: 99%

“…Figure 2 depicts the cumulative percentage of Hib meningitis cases as a function of age in 4 countries in the meningitis belt [13,50,67,74] and 5 elsewhere [14,19,23,57,69]. These data are compared with prevaccination data from Finland [78] and the United States [79].…”

Section: Characteristics Of Hib Diseasesmentioning

confidence: 99%

See 4 more Smart Citations

Burden of Meningitis and Other Severe Bacterial Infections of Children in Africa: Implications for Prevention

Peltola

2001

Clinical Infectious Diseases

118

View full text Add to dashboard Cite

Apart from meningococcal disease in the sub-Saharan meningitis belt, the incidence and impact of life-threatening bacterial diseases in children across Africa have not been quantified. The clinical and epidemiological data on pneumococcal, Haemophilus influenzae type b (Hib), and other forms of bacterial meningitis, as well as data on other severe bacterial infections throughout the continent were scrutinized. Pneumococci were the leading causative agents of nonepidemic meningitis and other bacteremic diseases, followed by Hib. Meningococcal diseases were less common. Mortality rates associated with pneumococcal, Hib, and meningococcal meningitis were 549 (45%) of 1211 patients, 389 (29%) of 1352 patients, and 104 (8%) of 1236 patients, respectively; sequelae occurred in 50%, 40%, and 10% of cases. At 0-4 years of age, the estimated incidences of Hib meningitis and all classic Hib diseases were 70 and 100 cases per 100,000 population per year, accounting for approximately 90,000 and 120,000 cases per year, respectively. Including older age groups and, especially, nonbacteremic Hib pneumonia in the estimates of Hib disease in Africa increased the overall numbers manifold; the numbers of pneumococcal infections were even greater. The only realistic way to combat these severe infections efficaciously would be through widespread vaccination, starting with Hib conjugates.

show abstract